Andrés Iñiguez1, MD; Sorin J. Brener2,3*, MD; Victor A. Jiménez1, MD; Akiko Maehara3,4, MD; Gary S. Mintz3, MD; Ke Xu3, PhD; Giora Weisz3,4,5, MD; Alexandra J. Lansky6, MD; Bernard De Bruyne7, MD, PhD; Patrick W. Serruys8, MD, PhD; Gregg W. Stone3,4, MD
1. Hospital Meixoeiro, University Hospital of Vigo, Vigo, Spain; 2. New York Methodist Hospital, Brooklyn, NY, USA; 3. Cardiovascular Research Foundation, New York, NY, USA; 4. New York-Presbyterian Hospital/Columbia University Medical Center, New York, N
Aims: Prior percutaneous coronary intervention (PCI) is increasingly encountered in acute coronary syndrome (ACS) patients, with uncertain significance. We sought to evaluate the impact o